46 results
Page 2 of 3
6-K
EX-99.1
iwy4j6u1 f0t
12 May 21
Biophytis Completed Recruitment of 155 Participants to the COVA Phase 2-3 Study with Sarconeos (BIO101) in COVID-19
7:48am
6-K
EX-99.1
coz4c6
11 May 21
Current report (foreign)
8:48am
6-K
EX-99.1
gyiux859
30 Apr 21
Current report (foreign)
6:12am
6-K
EX-99.1
siruledpukzfufas isz
29 Apr 21
Biophytis Receives €980,000 DeepTech Funding from BPI France for the development of Macuneos (BIO201) in dry AMD
7:02am
6-K
EX-99.1
twe5dwg
28 Apr 21
Current report (foreign)
9:31am
6-K
EX-99.1
spn4gxfjcbu d4
28 Apr 21
Biophytis - Convening of Another Combined General Meeting at a Later Date
6:01am
6-K
EX-99.1
ybl66ei 4nefu1bmry
22 Mar 21
Biophytis gives updates on its Phase 2-3 COVA study on COVID-19
4:15pm
20-F
u1jzblmx6hawyq
12 Mar 21
Annual report (foreign)
2:38pm
6-K
EX-99.1
j9ojhn43vxrpkomwk8
26 Feb 21
Biophytis Reports 2020 Full Year Results
4:06pm
6-K
EX-99.1
i669t4ds
17 Feb 21
Current report (foreign)
9:32am
6-K
hy18geeu
17 Feb 21
Current report (foreign)
9:32am
424B4
3v0st73ctwegr
11 Feb 21
Prospectus supplement with pricing info
12:00am
FWP
osockjwo
8 Feb 21
Free writing prospectus
4:33pm
F-1/A
2037rrb9vkq xefavu5j
4 Feb 21
Registration statement (foreign) (amended)
2:42pm
FWP
qjgxao
2 Feb 21
Free writing prospectus
9:51pm
F-1/A
8zvja
2 Feb 21
Registration statement (foreign) (amended)
5:27pm
F-1
j3np7nd itp
19 Jan 21
Registration statement (foreign)
5:05pm
DRS/A
bcxj9pi i02ns
23 Dec 20
Draft registration statement (amended)
12:00am
DRS
6uagkcoip
20 Nov 20
Draft registration statement
12:00am
F-1/A
07x9bhf44hd07
11 Jul 19
Registration statement (foreign) (amended)
5:32pm